Northern Trust (NTRS)

Cash & Equivalents

$45.70B

Quarterly · Period ending: · USD

NTRS logo

NTRS Cash & Equivalents

Latest reported$45.70B
NTRS Quarterly Cash & Equivalents ($1.39B → $45.70B)
High-resolution chart · PNG

NTRS cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Northern Trust Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
45,699,000,000
51,758,100,000
47,652,100,000
61,127,500,000
56,710,200,000
61,101,500,000
58,808,900,000
45,397,300,000
49,327,300,000
51,155,100,000
46,950,700,000
41,056,700,000
39,395,000,000
49,104,600,000
45,702,600,000
46,625,700,000
45,680,000,000
45,579,700,000
62,290,000,000
69,588,400,000
57,162,500,000
62,880,600,000
56,638,600,000
64,265,700,000
46,736,500,000
49,530,600,000
55,853,600,000
43,222,300,000
31,500,700,000
37,095,400,000
32,357,900,000
38,926,000,000
40,681,200,000
42,471,300,000
40,459,600,000
50,609,100,000
45,008,000,000
39,599,200,000
35,856,500,000
36,806,800,000
32,957,200,000
35,339,600,000
34,955,800,000
36,986,200,000
40,672,900,000
40,291,900,000
28,311,300,000
35,365,200,000
39,581,400,000
34,343,500,000
33,043,100,000
35,471,300,000
28,527,400,000
29,235,100,000
28,296,900,000
30,175,900,000
28,975,000,000
30,470,200,000
25,379,600,000
34,460,300,000
29,779,000,000
36,886,700,000
35,564,800,000
29,093,900,000
25,930,100,000
26,588,400,000
25,483,800,000
30,370,000,000
26,966,400,000
21,570,200,000
20,439,000,000
28,773,000,000
28,984,800,000
26,537,000,000
29,005,600,000
25,203,100,000
20,719,700,000
18,236,800,000
19,189,700,000
20,451,600,000
17,435,400,000
16,404,700,000
14,724,700,000
14,186,800,000
13,370,000,000
11,957,600,000
14,688,000,000
13,880,100,000
13,422,400,000
13,230,200,000
11,015,800,000
10,406,400,000
9,775,400,000
10,443,400,000
7,896,200,000
11,039,700,000
9,291,700,000
9,568,900,000
8,860,500,000
9,573,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.